iBio, Inc. (IBIO) Presents at 2026 EASD Annual Meeting - Slideshow

iBio, Inc. presented at the 2026 EASD Annual Meeting, providing an update on its pipeline of plant-based vaccines and therapeutics. The company highlighted the potential of its technology to produce large quantities of vaccines quickly and at a low cost.

The company also announced a collaboration with a major pharmaceutical company to develop a plant-based COVID-19 vaccine.